BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21166512)

  • 1. Clinical management of uterine papillary serous carcinoma.
    Roelofsen T; van Ham MA; de Hullu JA; Massuger LF
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):71-81. PubMed ID: 21166512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.
    Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W
    Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
    Alobaid A; Bruchim I; Verkooijen H; Gauthier P; Petignat P
    Eur J Surg Oncol; 2006 Apr; 32(3):358-62. PubMed ID: 16414233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
    Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
    Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
    Lindahl B; Persson J; Ranstam J; Willén R
    Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
    Fader AN; Boruta D; Olawaiye AB; Gehrig PA
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):21-9. PubMed ID: 19952744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in surgical stage I uterine papillary serous carcinoma.
    Havrilesky LJ; Secord AA; Bae-Jump V; Ayeni T; Calingaert B; Clarke-Pearson DL; Berchuck A; Gehrig PA
    Gynecol Oncol; 2007 Jun; 105(3):677-82. PubMed ID: 17355889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.
    Boruta DM; Gehrig PA; Fader AN; Olawaiye AB
    Gynecol Oncol; 2009 Oct; 115(1):142-153. PubMed ID: 19592079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine papillary serous carcinoma.
    Moore KN; Fader AN
    Clin Obstet Gynecol; 2011 Jun; 54(2):278-91. PubMed ID: 21508697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma.
    Sagr ER; Denschlag D; Kerim-Dikeni A; Stanimir G; Gitsch G; Gilbert L
    Anticancer Res; 2007; 27(2):1213-7. PubMed ID: 17465265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
    Wu M; Lang J; Guo L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome.
    Faratian D; Stillie A; Busby-Earle RM; Cowie VJ; Monaghan H
    Int J Gynecol Cancer; 2006; 16(3):972-8. PubMed ID: 16803471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.